The term “microbicide” refers to substances being studied that could be used in the vagina and/or rectum to reduce the risk of HIV infection via sexual exposure. There are no licensed microbicides available today. Simple, easy-to-use microbicides would help these individuals take control of their own health—while offering people everywhere an additional, needed option. The graphics below represent key facts about the microbicide field.
Microbicides by the Numbers: Science, products, money and more
MPT Products in the Pipeline: Selected highlights
This table shows which MPTs are further along in testing for both sustained-release and on-demand products. Women will have different needs and preferences throughout their lives. An array of different types of products is key to meeting the varying needs of different women. Excerpted from the MPTs factsheet.
Progress Toward an Vaccines
This one-page infographic from NIAID highlights challenges and progress in the search for a vaccines, and also includes brief descriptions of some of the approaches to vaccine development that scientists are exploring today.
Vaccine Strategies in Clinical Trials (2016)
We know that an AIDS vaccine is possible and that a vaccine will be an important part of a long-term strategy to end the AIDS epidemic. The road ahead is long, but clinical trials—even those with disappointing results—and early-stage research provide critical clues to the way forward.
HIV Vaccine Research: An Update
A quick, colorful and comprehensive overview of HIV vaccine research. Four pages, five top-line updates, this is a speedy read, designed to give a sense of the momentum and major issues coming up in the year to come.
Anatomy of a Target – Treatment U=U
In Px Wire, our quarterly newsletter, we looked at the strengths and limitations of new PEPFAR targets, new UNAIDS targets, new guidelines on ART and PrEP from the WHO and new Sustainable Development Goals.
In this excerpt from our centerspread graphic, we take a closer look at antiretroviral therapy and Treatment U=U.
Anatomy of a Target – PrEP
In Px Wire, our quarterly newsletter, we looked at the strengths and limitations of new PEPFAR targets, new UNAIDS targets, new guidelines on ART and PrEP from the WHO and new Sustainable Development Goals.
In this excerpt from our centerspread graphic, we take a closer look at PrEP.
Anatomy of a Target – VMMC
In Px Wire, our quarterly newsletter, we looked at the strengths and limitations of new PEPFAR targets, new UNAIDS targets, new guidelines on ART and PrEP from the WHO and new Sustainable Development Goals.
In this excerpt from our centerspread graphic, we take a closer look at VMMC.
Anatomy of a Target – DREAMS
In Px Wire, our quarterly newsletter, we looked at the strengths and limitations of new PEPFAR targets, new UNAIDS targets, new guidelines on ART and PrEP from the WHO and new Sustainable Development Goals.
In this excerpt from our centerspread graphic, we take a closer look at the DREAMS program.
The New Context for HIV Prevention: Is the world on target?
In this issue of Px Wire, our centerspread graphic looks at the sum total of the new targets and guidelines and gives our “take” on whether the current context is on target.